O76074 |
PDE5A_HUMAN |
Hypertension [ICD-11: BA00-BA04] |
O76074 |
PDE5A_HUMAN |
Innate/adaptive immunodeficiency [ICD-11: 4A00] |
O76074 |
PDE5A_HUMAN |
Sexual dysfunction [ICD-11: HA00-HA01] |
O76074 |
PDE5A_HUMAN |
Tonus and reflex abnormality [ICD-11: MB47] |
O76074 |
PDE5A_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
O76074 |
PDE5A_HUMAN |
Chronic obstructive pulmonary disease [ICD-11: CA22] |
O76074 |
PDE5A_HUMAN |
Raynaud phenomenon [ICD-11: BD42] |
O76074 |
PDE5A_HUMAN |
Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
O76074 |
PDE5A_HUMAN |
Angina pectoris [ICD-11: BA40] |
O76074 |
PDE5A_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
O76074 |
PDE5A_HUMAN |
Asthma [ICD-11: CA23] |
P03372 |
ESR1_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P03372 |
ESR1_HUMAN |
Acquired prion disease [ICD-11: 8E01] |
P03372 |
ESR1_HUMAN |
Adrenal cancer [ICD-11: 2D11] |
P03372 |
ESR1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P03372 |
ESR1_HUMAN |
Contraceptive management [ICD-11: QA21] |
P03372 |
ESR1_HUMAN |
Dyspareunia [ICD-11: GA12] |
P03372 |
ESR1_HUMAN |
Female infertility [ICD-11: GA31] |
P03372 |
ESR1_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
P03372 |
ESR1_HUMAN |
Male infertility [ICD-11: GB04] |
P03372 |
ESR1_HUMAN |
Menopausal disorder [ICD-11: GA30] |
P03372 |
ESR1_HUMAN |
Menstrual cycle bleeding disorder [ICD-11: GA20] |
P03372 |
ESR1_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P03372 |
ESR1_HUMAN |
Pituitary gland disorder [ICD-11: 5A60-5A61] |
P03372 |
ESR1_HUMAN |
Skeletal anomaly [ICD-11: LD24] |
P03372 |
ESR1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P03372 |
ESR1_HUMAN |
Vaginitis [ICD-11: GA02] |
P03372 |
ESR1_HUMAN |
Virus infection [ICD-11: 1A24-1D9Z] |
P03372 |
ESR1_HUMAN |
Endometriosis [ICD-11: GA10] |
P03372 |
ESR1_HUMAN |
Female genital tract noninflammatory disorder [ICD-11: GA1Y] |
P03372 |
ESR1_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P03372 |
ESR1_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P03372 |
ESR1_HUMAN |
Breast in situ carcinoma [ICD-11: 2E65] |
P03372 |
ESR1_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
P03372 |
ESR1_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P03372 |
ESR1_HUMAN |
Brain cancer [ICD-11: 2A00] |
P03372 |
ESR1_HUMAN |
Metastatic tumour [ICD-11: 2D50-2E2Z] |
P03372 |
ESR1_HUMAN |
Irregularities [ICD-11: N.A.] |
P03372 |
ESR1_HUMAN |
Trematode disease [ICD-11: 1F8Y] |
P03372 |
ESR1_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P03372 |
ESR1_HUMAN |
Eye disorder [ICD-11: 9A01-9A0Z] |
P03372 |
ESR1_HUMAN |
Dissociative neurological symptom disorder [ICD-11: 6B60] |
P03372 |
ESR1_HUMAN |
Thrombocytopenia [ICD-11: 3B64] |
P03372 |
ESR1_HUMAN |
Atrophy [ICD-11: 9A2Y-9C40] |
P03372 |
ESR1_HUMAN |
Joint pain [ICD-11: ME82] |
P03372 |
ESR1_HUMAN |
Sexual dysfunction [ICD-11: HA00-HA01] |
P03372 |
ESR1_HUMAN |
Leukaemia [ICD-11: 2A60-2B33] |
Q92731 |
ESR2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q92731 |
ESR2_HUMAN |
Cushing syndrome [ICD-11: 5A70] |
Q92731 |
ESR2_HUMAN |
Menopausal disorder [ICD-11: GA30] |
Q92731 |
ESR2_HUMAN |
Vasomotor/allergic rhinitis [ICD-11: CA08] |
Q92731 |
ESR2_HUMAN |
Hepatitis virus infection [ICD-11: 1E50-1E51] |
Q92731 |
ESR2_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
Q92731 |
ESR2_HUMAN |
Prostate cancer [ICD-11: 2C82] |
Q92731 |
ESR2_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
Q92731 |
ESR2_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
Q92731 |
ESR2_HUMAN |
Prostate hyperplasia [ICD-11: GA90] |
Q92731 |
ESR2_HUMAN |
Sepsis [ICD-11: 1G40-1G41] |
Q92731 |
ESR2_HUMAN |
Irregularities [ICD-11: N.A.] |
Q92731 |
ESR2_HUMAN |
Trematode disease [ICD-11: 1F8Y] |
Q92731 |
ESR2_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
Q92731 |
ESR2_HUMAN |
Thrombocytopenia [ICD-11: 3B64] |
Q92731 |
ESR2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q92731 |
ESR2_HUMAN |
Herpes simplex infection [ICD-11: 1F00] |
Q92731 |
ESR2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |